Titlebook: Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy; Anubhab Mukherjee,Vijay Sagar Madamsetty,Sudip Muk Book 2021 Spri

Intermediary

書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy影響因子(影響力)




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy影響因子(影響力)學(xué)科排名




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy被引頻次




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy被引頻次學(xué)科排名




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy年度引用




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy年度引用學(xué)科排名




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy讀者反饋




書(shū)目名稱Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy讀者反饋學(xué)科排名

Cardioversion

hematuria

Immunomodulatory Organic and Polymer Nanomedicine in Cancer Therapy,

Tincture

Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy

Ingest

degradation

Immunomodulatory Protein Nanoparticles in Cancer Therapy,ving the negative regulation over T cells [6–8]. Recent FDA approval of CAR-T therapy (chimeric antigen receptor T-cell therapy by genetically engineered T cells for antigen‐specific tumor therapy) for B‐cell and non‐Hodgkin lymphoma therapy is also emerging news in the immunotherapy field [9, 10].

degradation

Book 2021cer therapy. This book highlights various immunomodulatory nanomaterials (including organic, polymer, inorganic, liposomes, viral, and protein nanoparticles) and their role in cancer therapy. Additionally, the mechanism of immunomodulation is reviewed in detail. Finally, the challenges of these ther

NIP

Theodore P. Snow Jr.,George Wallersteinty of the natural immune system to target cancerous cells is greatly diminished [3]. However, so far, the clinical effect of most cancer immunotherapies are not satisfactory. Hence, there is a great need to develop efficient immune therapies for the betterment of cancer treatment.

accessory

Immunomodulatory Viral Nanoparticles in Cancer Therapy,ty of the natural immune system to target cancerous cells is greatly diminished [3]. However, so far, the clinical effect of most cancer immunotherapies are not satisfactory. Hence, there is a great need to develop efficient immune therapies for the betterment of cancer treatment.

量被毀壞